by Market Research Centre 1 | Oct 2, 2020 | Consumer, COVID-19, Pharma/Bio, Technology
An increased adoption of contactless surfaces post pandemic will drive the home automation and security markets. Systems encompassing voice activation technology will become increasingly popular among consumers. Sales of smart home devices will see a 30%...
by Market Research Centre 5 | Sep 29, 2020 | Connected Health, Healthcare, Medtech
Telemedicine is the delivery of medical services to any location with the help of advanced telecommunications technology. Telemedicine technology incorporates digital communication and telecommunications technologies to treat patients residing in any location...
by Market Research Centre 1 | Aug 10, 2020 | COVID-19, Innovation
“As consumers begin to spend money with greater conscience, brands will ultimately have no choice but to reconsider their stance towards sustainability in order to survive in a post-COVID-19 world” Euromonitor – From Sustainability to Purpose: New Values Driving...
by Market Research Centre 1 | Aug 6, 2020 | Healthcare, Technology
Considered as the next-gen of cellular technology, 5G enables high-speed data transfer in Gbps speed and extremely low latency communication, as desired by emerging applications, such as Tele-Robotic surgeries and autonomous vehicles. Embedded in edge devices...
by Market Research Centre 1 | Jul 17, 2020 | COVID-19
“Even though money is a concern due to the economic recession, people’s priorities are changing; purchasing food, especially healthy, good quality food will become a top priority. For example, when asked about expected changes in future spending as a result of...
by Market Research Centre 3 | Jun 29, 2020 | COVID-19, Pharma/Bio
“The COVID-19 pandemic has brought to the fore several gaps in our understanding of health, wellness, and prevention. It has the potential to disrupt the standard norms of prevention and treatment. Even though world organizations thought they had conquered the...
by Market Research Centre 1 | Jun 26, 2020 | COVID-19
“Executive leaders have implemented various digital innovations to respond to the COVID-19 crisis, sometimes within days. Many of these gains are like donut tires: you don’t want to drive too far with them. Executive leaders should now make these hard-won gains...
by Market Research Centre 1 | Jun 8, 2020 | COVID-19
“While Coronavirus (COVID-19) lockdown restrictions are easing in many markets, many activities, from concerts to bars to cosmetics counters, are likely to remain off-limits for months to come. This is driving a vast shift in spending, creating new opportunities for...
by Market Research Centre 1 | May 19, 2020 | COVID-19
“Regardless, the duration and severity of COVID-19’s impact on economies and sectors will undoubtedly vary. Companies would do well to set in motion a “look ahead, anticipate, and adjust” roadmap. Over the short term, companies should explore supply chain...
by Market Research Centre 1 | Apr 27, 2020 | COVID-19
“The CE-marking grants European approval for Co-Diagnostics’ in vitro diagnostic (IVD) test for detection of COVID-19. This is reported to be the first CE marking obtained by a US company for a coronavirus IVD.” – Frost & Sullivan – Recent Innovations...
by Market Research Centre 1 | Apr 16, 2020 | COVID-19, Food/Beverages
“What’s more, the coronavirus crisis (see Lead Editorial) has hit the foodservice business hard everywhere. It will likely hit Oatly hard too, for a large percentage of its sales relies on this channel.” New Nutrition Business – Oat-milk surge cannibalises soy,...
by Market Research Centre 1 | Mar 30, 2020 | COVID-19, Health, Healthcare
“The coronavirus outbreak is wreaking havoc on the global economy. The Chinese economy is being adversely hampered, with other economies across the globe facing severe negative effects as well. Frost & Sullivan has analysed the outlook for three scenarios, the...
by Market Research Centre 1 | Mar 12, 2020 | Connected Health, Health, Healthcare, Medtech, Medtech, Pharma/Bio
“The global orphan drugs market should reach $315.6 billion by 2024 from $127.5 billion in 2017 at a compound annual growth rate (CAGR) of 13.8% for the forecast period of 2017 to 2024.” BCC Research – ROI in Pharmaceutical R&D: How to Halt the Decline BCC...
by Market Research Centre 1 | Jan 24, 2020 | Healthcare, Pharma/Bio
“At present, neurodegenerative diseases represent one of the main causes of death in the industrialized economy. Overall characterized by a loss of neurons in particular regions of the nervous system, the subsequent decline in cognitive and motor function that...
by Market Research Centre 1 | Jan 16, 2020 | Healthcare, Pharma/Bio
The global enterprise imaging market is estimated at $933.7 million in 2018. The market is picking up pace in developed countries and other major geographies that have high penetration of radiology and cardiology PACS, enterprise-level VNA and electronic health...
